← Leaderboards
George A. Garcia
University Of Michigan At Ann Arbor
$4,891,879
Attributed
$4,891,879
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829.7K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,891,879 · 4
By mechanism
R01$4,038,465 · 2
T32$456,136 · 1
R21$397,278 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Victor J. Dirita$11,144,772
- David R Engelke$5,495,965
- Nils G Walter$19,480,840
- Alice Telesnitsky$37,945,631
- E Neil Marsh$6,332,365
Others in their field
Top investigators on “High Throughput Screening”
- Richard A Gibbs · Baylor College Of Medicine$250,166,309
- Leonard Freedman · Leidos Biomedical Research, Inc.$249,633,249
- David Heimbrook · Leidos Biomedical Research, Inc.$181,270,700
- Peter B. Gilbert · Fred Hutchinson Cancer Center$146,111,713
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
Research focus
High Throughput ScreeningDesignPharmaceutical PreparationsPropertyGenetic TranscriptionAnalogEvaluationIn VitroBaseResistant StrainAntibioticsPublic Health RelevanceBiochemistryDrug InteractionsDrug Resistance In TuberculosisDrug IndustryAptamerDrug KineticsEnzymatic BiochemistryClinically RelevantDna-Directed Rna PolymeraseCessation Of LifeCo-InfectionBactericide
Grant awards (12)
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection$641,007
R01 · FY2019 · AI · contact PI
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection$641,007
R01 · FY2018 · AI · contact PI
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection$641,007
R01 · FY2017 · AI · contact PI
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection$641,007
R01 · FY2016 · AI · contact PI
Interdepartmental Training in Pharmacological Sciences$456,136
T32 · FY2015 · GM · contact PI
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection$373,580
R01 · FY2015 · AI · contact PI
Targeting Bacterial Virulence Transcription Factors, a Novel Antibiotic Approach$153,945
R21 · FY2011 · AI · contact PI
Targeting Bacterial Virulence Transcription Factors, a Novel Antibiotic Approach$243,333
R21 · FY2010 · AI · contact PI
Substrate Recognition of a tRNA Modifying Enzyme$271,897
R01 · FY2006 · GM · contact PI
Substrate Recognition of a tRNA Modifying Enzyme$278,440
R01 · FY2005 · GM
Substrate Recognition of a tRNA Modifying Enzyme$278,440
R01 · FY2004 · GM
Substrate Recognition of a tRNA Modifying Enzyme$272,080
R01 · FY2003 · GM